Versameb to present novel data on its lead asset, VMB-100 at 9th International mRNA Health Conference

/PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces that...

Related Keywords

Berlin ,Germany ,Switzerland ,Isabel Ferreira ,Sina Zimmerli ,Klaas Zuideveld ,Pascale Birrer ,Friedrich Metzger ,Claudia Bohnert ,Tatsuo Satoh ,Versameb Versagile ,Petra Hillmann ,Isabelle Kappeler ,Nicole Stiffler ,Justin Antony Selvaraj ,Rna Health Conference ,Linkedin ,Chief Scientific Officer ,Stress Urinary Incontinence ,Chief Executive Officer ,Versameb ,Pharmaceuticals ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,